Humacyte HUMA
NASDAQ HUMA
$0.66 -0.02 (-2.85%)
As of: Aug 21, 2026 · 11:45 AM EDT

Humacyte (HUMA) Gross Margin (QoQ) (2025 - 2026)

Humacyte (HUMA) Gross Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.51 Bn 78.51 Bn 3.93 Bn
3 Argenx Se 65.74 Bn 60.56 Bn 1.37 Bn
4 Moderna 59.39 Bn 54.26 Bn 52.00 Mn
5 BeOne Medicines 42.24 Bn 37.15 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.78 Bn 28.47 Bn 992.69 Mn
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn
9 Royalty Pharma 27.22 Bn 26.39 Bn -
10 Humacyte 154.82 Mn 154.82 Mn -825,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 10,852.00
Mar 31, 2026 153,304.00
Dec 31, 2025 -191,023.00
Sep 30, 2025 3,624.00
Jun 30, 2025 -4,233.00